2016
Maltreatment, family environment, and social risk factors: Determinants of the child welfare to juvenile justice transition among maltreated children and adolescents
Vidal S, Prince D, Connell CM, Caron CM, Kaufman JS, Tebes JK. Maltreatment, family environment, and social risk factors: Determinants of the child welfare to juvenile justice transition among maltreated children and adolescents. Child Abuse & Neglect 2016, 63: 7-18. PMID: 27886518, PMCID: PMC5283859, DOI: 10.1016/j.chiabu.2016.11.013.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAge FactorsBlack or African AmericanChildChild AbuseChild Protective ServicesChild, PreschoolCultural DeprivationDomestic ViolenceFemaleHispanic or LatinoHumansJuvenile DelinquencyLife Change EventsMaleProspective StudiesPublic AssistanceRhode IslandRisk FactorsSocial JusticeWhite PeopleConceptsJuvenile justice systemChild protective services investigationJustice systemSocial risk factorsSystem transitionsChild welfare systemIncidents of neglectRecurrence of maltreatmentTypes of abuseFamily environmentWelfare systemChild welfareCPS investigationSubtypes of maltreatmentServices investigationTailoring servicesMaltreatmentAdverse family environmentRisk of transitionRace/ethnicityPatterns of riskChronicity of maltreatmentPovertyWelfareExplores
2006
Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer
Berry D, Cirrincione C, Henderson I, Citron M, Budman D, Goldstein L, Martino S, Perez E, Muss H, Norton L, Hudis C, Winer E. Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer. Obstetrical & Gynecological Survey 2006, 61: 584-585. DOI: 10.1097/01.ogx.0000234789.05150.7c.Peer-Reviewed Original ResearchER-negative patientsER-positive patientsER-positive tumorsER-negative tumorsNode-positive breast cancerER-negative womenEstrogen receptor statusBreast cancerOverall survivalER statusLymph node-positive breast cancerER-positive breast cancerModern intensive chemotherapyWeak prognostic factorER-positive diseaseLeukemia Group BDisease-free survivalER-negative diseaseOverall survival ratePatterns of riskAdjuvant chemotherapyChemotherapy trialsEndocrine treatmentIntensive chemotherapyRecurrent disease
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply